You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
|
|---|---|
| Published in |
Frontiers in Pharmacology, September 2022
|
| DOI | 10.3389/fphar.2022.960323 |
| Pubmed ID | |
| Authors |
Yihang Qi, Wenxiang Zhang, Ray Jiang, Olivia Xu, Xiangyi Kong, Lin Zhang, Yi Fang, Jingping Wang, Jing Wang |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 11 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 2 | 18% |
| Unknown | 9 | 82% |
| Readers by discipline | Count | As % |
|---|---|---|
| Environmental Science | 1 | 9% |
| Sports and Recreations | 1 | 9% |
| Unknown | 9 | 82% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2022.
All research outputs
#20,743,007
of 23,342,232 outputs
Outputs from Frontiers in Pharmacology
#10,613
of 16,802 outputs
Outputs of similar age
#323,136
of 407,472 outputs
Outputs of similar age from Frontiers in Pharmacology
#856
of 1,544 outputs
Altmetric has tracked 23,342,232 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,802 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 407,472 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,544 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.